Late immune-related adverse events in long-term responders to PD-1/PD-L1 checkpoint inhibitors: A multicentre studyOlga Nigro, Corrado Ficorella, Vincenzo Adamo et al.|European Journal of Cancer|2020Cited by 71
Concomitant medications during immune checkpoint blockage in cancer patients: Novel insights in this emerging clinical scenarioGiovanni Rossi, Alessandro Russo, Aldo Pezzuto et al.|Critical Reviews in Oncology/Hematology|2019Cited by 66
Biological effects of verbascoside and its anti-inflammatory activity on oral mucositis: a review of the literatureOlga Nigro, Graziella Pinotti, Alessandro Tuzi et al.|Anti-Cancer Drugs|2019Cited by 41
Psoriatic Arthritis Induced by Anti-PD1 and Treated with Apremilast: A Case Report and Review of the LiteratureOlga Nigro, Carlo Selmi, Graziella Pinotti et al.|Immunotherapy|2020Cited by 17
On-target Toxicities Predictive of Survival in Metastatic Renal Cell Carcinoma (mRCC) Treated With Sunitinib: A Multicenter Retrospective StudyElena Bolzacchini, Francesco Dentali, Graziella Pinotti et al.|Clinical Genitourinary Cancer|2019Cited by 7